Race for coronavirus treatment

Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.

The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.

The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.

It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.

The trial is due to start next week.

Last local news

Evening Update Monday 26 July 2021

In Corsica, the Prefect of the Haute-Corse department has announced that establishments open to the public such as bars and restaurants will have to c... Evening Update Monday 26 July 2021 Read More

26/07/2021

Lunchtime News Monday July 26th 2021

U-Turns- Many people say they're confused about the fresh restrictions aimed at reducing the spread of coronavirus in the Alpes Maritimes.... Lunchtime News Monday July 26th 2021 Read More

26/07/2021

French and Riviera News Monday July 26th 2021

Aude inferno- A massive fire that’s so far destroyed more than 900 hectares of forest land in the Aude department is still not completely under contro... French and Riviera News Monday July 26th 2021 Read More

26/07/2021

Evening Update Friday 23 July 2021

The president of the Scientific Council Jean-Francois Delfraissy has said that there will probably be 50,000 Covid-19 caes per day in France at the be... Evening Update Friday 23 July 2021 Read More

23/07/2021